LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 50 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $33,908,000 | +7.9% | 4,551,343 | +0.7% | 4.33% | -31.7% |
| Q4 2016 | $31,418,000 | -10.3% | 4,520,643 | +6.2% | 6.35% | +3.2% |
| Q3 2016 | $35,038,000 | -0.3% | 4,257,347 | -1.9% | 6.15% | -21.3% |
| Q2 2016 | $35,142,000 | +121.4% | 4,338,557 | +38.8% | 7.81% | +41.0% |
| Q1 2016 | $15,876,000 | -35.5% | 3,125,198 | -2.0% | 5.54% | -34.7% |
| Q4 2015 | $24,608,000 | +34.3% | 3,187,607 | +0.2% | 8.48% | +78.0% |
| Q3 2015 | $18,322,000 | -31.6% | 3,180,913 | +8.8% | 4.76% | -35.5% |
| Q2 2015 | $26,805,000 | +3.0% | 2,923,065 | +36.0% | 7.38% | -26.1% |
| Q1 2015 | $26,035,000 | – | 2,149,907 | – | 9.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
| Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
| FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
| Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
| Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
| Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
| Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
| QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
| Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |